Home / Share Price Target / Auropharma
Aurobindo Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Aurobindo Pharma Limited | |||
 | Symbol: AUROPHARMA | ||
| Price: ₹1,249 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Aurobindo Pharma Brief Company Overview
- 1.1: Aurobindo Pharma Limited: A Leading Pharmaceutical Company
- 1.2: Aurobindo Pharma Financial Performance
- 1.2.1: Is Aurobindo Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Aurobindo Pharma Share Price Target For 2024
- 2.1.1: Aurobindo Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Aurobindo Pharma Share Price Prediction For 2024
- 2.2: Aurobindo Pharma Share Price Target For 2025
- 2.2.1: Aurobindo Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Aurobindo Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Aurobindo Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Aurobindo Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Aurobindo Pharma Past Performance
Aurobindo Pharma Brief Company Overview
Aurobindo Pharma Limited: A Leading Pharmaceutical Company
- Key Products and Services: Generic formulations, active pharmaceutical ingredients (API), antiretroviral drugs, biocatalysts, and contract services covering the entire drug lifecycle
- History and Market Presence: Founded in 1986, headquartered in Hyderabad, India; operates in India, the US, Europe, and internationally
- Reputation: Renowned in the industry for its diverse product range and commitment to quality
- Commitment: Dedicated to providing affordable and accessible healthcare solutions
Advertisement
Aurobindo Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 78,443.07 Crore | Market valuation of Aurobindo Pharma's shares. |
| Revenue (TTM) | 29,718.37 Crore | Total revenue generated by Aurobindo Pharma over the past twelve months. |
| Net Income (TTM) | +3,521.44 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 16.06% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 11.84% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +10.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +61.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 22.27 | Company's total debt divided by total shareholder equity. |
| Total Debt | 6,647.62 Crore | Sum of Aurobindo Pharma's current & long-term financial obligations. |
| Total Cash | 6,326.36 Crore | Total amount of liquid funds available to Aurobindo Pharma. |
| Beta | 0.59 | Beta is less than 1 indicating that the Aurobindo Pharma's price is less volatile than the market. |
Is Aurobindo Pharma A Good Buy For Long Term?
No valid response content found
To predict the Aurobindo Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Aurobindo Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Aurobindo Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aurobindo Pharma shares in 2024, see the table below.
Advertisement
Aurobindo Pharma Share Price Target Table For 2024
| Aurobindo Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1287.46 (+3.07%) | Fibonacci Extension Level 150% |
| 2024 Target 2 | 1272.25 (+1.86%) | Fibonacci Extension Level 100% |
| 2024 Target 1 | 1256.18 (+0.57%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 1249.00 | Aurobindo Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1246.80 (-0.18%) | Price Action: Chart |
| Stop Loss 2 | 1233.30 (-1.26%) | Technical Indicator: MA250 |
| Stop Loss 3 | 1216.72 (-2.59%) | Fibonacci Retracement Extended 82.6% |
Summary: Aurobindo Pharma Share Price Prediction For 2024
In summary, Aurobindo Pharma has surged by ₹165.00, achieving a notable +15.22% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Aurobindo Pharma for 2024 predicts an additional rise of 0.57% to 3.07% by the end of 2024 with three potential targets T1: 1256.18, T2: 1272.25, T3: 1287.46. Stop Loss at SL1: 1246.80, SL2: 1233.30, SL3: 1216.72.
Aurobindo Pharma has a 52-week high of ₹1592.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹958.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Aurobindo Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aurobindo Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Aurobindo Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aurobindo Pharma shares in 2025, see the table below.
Advertisement
Aurobindo Pharma Share Price Target Table For 2025
| Aurobindo Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1790.01 (+43.31%) | Price Action: Chart |
| 2025 Target 2 | 1756.63 (+40.64%) | Fibonacci Extension Level 123.6% |
| 2025 Target 1 | 1733.12 (+38.76%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1249.00 | Aurobindo Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1114.00 (-10.81%) | Price Action: Mar 2024 High |
| Stop Loss 2 | 1099.90 (-11.94%) | Price Action: Dec 2023 High |
| Stop Loss 3 | 1063.75 (-14.84%) | Price Action: May 2021 High |
Summary: Aurobindo Pharma Share Price Prediction For 2025
In summary, Aurobindo Pharma has surged by ₹165.00, achieving a notable +15.22% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Aurobindo Pharma for 2025 predicts an additional rise of 38.76% to 43.31% by the end of 2025 with three potential targets T1: 1733.12, T2: 1756.63, T3: 1790.01. Stop Loss at SL1: 1114.00, SL2: 1099.90, SL3: 1063.75.
Aurobindo Pharma has a All-Time high of ₹1592.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹958.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Aurobindo Pharma, we have created a specific page for that check here: Aurobindo Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Aurobindo Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Aurobindo Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 8.31% over the next 15 years.
For complete year by year Aurobindo Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Aurobindo Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Aurobindo Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,249 | [Current Price] |
| 2024 | ₹1,568.35 | 25.56% |
| 2025 | ₹1,679.3 | 7.07% |
| 2026 | ₹1,782.22 | 6.12% |
| 2027 | ₹1,936.26 | 8.64% |
| 2028 | ₹2,409.98 | 24.46% |
| 2029 | ₹2,647.82 | 9.86% |
| 2030 | ₹2,695.28 | 1.79% |
| 2031 | ₹2,744.07 | 1.81% |
| 2032 | ₹2,879.44 | 4.93% |
| 2033 | ₹3,479.71 | 20.84% |
| 2034 | ₹3,727.28 | 7.11% |
| 2035 | ₹3,711.25 | -0.44% |
| 2036 | ₹3,705.92 | -0.15% |
| 2037 | ₹3,822.62 | 3.14% |
| 2038 | ₹4,549.43 | 19.01% |
| 2039 | ₹4,792.39 | 5.34% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aurobindo Pharma Past Performance
- In 1995, Aurobindo Pharma opening price was ₹2.06
- As of Thu 14 Nov 2024 the price stands at ₹1,249.
- This represents a Compound Annual Growth Rate (CAGR) of 23.81%.
- In 29 years, an investment of 10,000 would have become ₹60.63 Lakh.
As we wrap up, we hope you like our study on Aurobindo Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Aurobindo Pharma Share Price History
- Aurobindo Pharma Price Target Tomorrow
- Aurobindo Pharma Dividend History
- Aurobindo Pharma Bonus History
- Aurobindo Pharma Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
